Search

everythinglearnresearchcommunity

for

Search:↓

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Progesterone protects brain cells, but Provera does not.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

5alpha-DHP may be a safe, effective treatment for certain seizures without causing sedation.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Quercetin-loaded nanogels show promise for treating alopecia effectively.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

The method accurately measures certain steroids in human hair, showing different levels in males and females.

Progesterone protects neurons from damage by converting to allopregnanolone, which works through GABAA receptors.

Canine hair follicle cells convert progesterone into various metabolites, mainly cortisol.

The study found ways to create important compounds for male health from olive waste.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Fetal environments contain various chemicals that may disrupt hormones.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Certain Dibenzo derivatives may help treat prostate cancer.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

IL-17-producing γδ T cells help improve bone healing.

A new method accurately measures nine neuroactive steroids in small blood samples, helping to study brain diseases.

A neurosteroid can reduce caffeine-induced anxiety in rats.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.